
UNH Commentator$XTALPI(02228.HK) Jingtai Holdings will participate in the 6th Pharmaceutical Crystallization Summit held in Plainsboro, New Jersey from October 19 to 21. As one of the sponsors, R. Alex Mayo will represent Jingtai at the event.
1. Introduction
R. Alex Mayo: Business Development Manager, Ph.D. in Computational Chemistry/Crystallography, with industrial experience in pharmaceutical solid form development. Passionate about using experimental screening (crystallization, structural and thermal analysis) and computational methods (crystal structure prediction) to solve research problems in molecular solid forms (polymorphs, multicomponent crystals, amorphous).
2. Presentation Content
Will focus on Jingtai Technology's unique solid-state platform, emphasizing the synergy between computational modeling, machine learning and experiments. Through the combination of computation and experimentation, it provides data-intensive, comprehensive results to transform predictions into reliable crystal form performance.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.




